Prevalence of human Papillomavirus associated oropharyngeal and oral squamous cell carcinoma in Asian countries: A systematic review and large-scale meta-analysis

1 Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-917. Search in Google Scholar

2 Ellington TD, Henley SJ, Senkomago V, O’Neil ME, Wilson RJ, Singh S, et al. Trends in Incidence of Cancers of the Oral Cavity and Pharynx - United States 2007-2016. MMWR Morb Mortal Wkly Rep. 2020;69(15):433-8. Search in Google Scholar

3 Chi AC, Day TA, Neville BW. Oral cavity and oropharyngeal squamous cell carcinoma--an update. CA Cancer J Clin. 2015;65(5):401-21. Search in Google Scholar

4 Hussein AA, Helder MN, de Visscher JG, Leemans CR, Braakhuis BJ, de Vet HCW, et al. Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: A systematic review. Eur J Cancer. 2017;82:115-27. Search in Google Scholar

5 Gan LL, Zhang H, Guo JH, Fan MW. Prevalence of human papillomavirus infection in oral squamous cell carcinoma: a case-control study in Wuhan, China. Asian Pac J Cancer Prev. 2014;15(14):5861-5. Search in Google Scholar

6 Argirion I, Zarins KR, McHugh J, Cantley RL, Teeramatwanich W, Laohasiriwong S, et al. Increasing prevalence of HPV in oropharyngeal carcinoma suggests adaptation of p16 screening in Southeast Asia. J Clin Virol. 2020;132:104637. Search in Google Scholar

7 Xu T, Shen C, Wei Y, Hu C, Wang Y, Xiang J, et al. Human papillomavirus (HPV) in Chinese oropharyngeal squamous cell carcinoma (OPSCC): A strong predilection for the tonsil. Cancer Med. 2020;9(18):6556-64. Search in Google Scholar

8 de Sanjose S, Brotons M, Pavon MA. The natural history of human papillomavirus infection. Best Pract Res Clin Obstet Gynaecol. 2018;47:2-13. Search in Google Scholar

9 Chen F, Yan L, Liu F, Huang J, Liu F, Wu J, et al. Oral human papillomavirus infection, sexual behaviors and risk of oral squamous cell carcinoma in southeast of China: A case-control study. J Clin Virol. 2016;85:7-12. Search in Google Scholar

10 Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26(4):612-9. Search in Google Scholar

11 Gooi Z, Chan JY, Fakhry C. The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer. Laryngoscope. 2016;126(4):894-900. Search in Google Scholar

12 Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer--systematic review and meta-analysis of trends by time and region. Head Neck. 2013;35(5):747-55. Search in Google Scholar

13 Stjernstrom KD, Jensen JS, Jakobsen KK, Gronhoj C, von Buchwald C. Current status of human papillomavirus positivity in oropharyngeal squamous cell carcinoma in Europe: a systematic review. Acta Otolaryngol. 2019;139(12):1112-6. Search in Google Scholar

14 Sathish N, Wang X, Yuan Y. Human Papillomavirus (HPV)-associated Oral Cancers and Treatment Strategies. J Dent Res. 2014;93(7 Suppl):29S-36S. Search in Google Scholar

15 Rathish D, Wijerathne B, Khan R. Human Papillomavirus-Associated Oral Squamous Cell Carcinoma Among Adults Living in South-Central Asia: A Systematic Review. Indian Journal of Otolaryngology and Head & Neck Surgery. 2020. Search in Google Scholar

16 Bukhari N, Joseph JP, Hussain SS, Khan MA, Wakim MJY, Yahya EB, et al. Prevalence of Human Papilloma Virus Sub Genotypes following Head and Neck Squamous Cell Carcinomas in Asian Continent, A Systematic Review Article. Asian Pac J Cancer Prev. 2019;20(11):3269-77. Search in Google Scholar

17 Kim Y, Joo YH, Kim MS, Lee YS. Prevalence of high-risk human papillomavirus and its genotype distribution in head and neck squamous cell carcinomas. J Pathol Transl Med. 2020;54(5):411-8. Search in Google Scholar

18 Jiarpinitnun C, Larbcharoensub N, Pattaranutaporn P, Chureemas T, Juengsamarn J, Trachu N, et al. Characteristics and Impact of HPV-Associated p16 Expression on Head and Neck Squamous Cell Carcinoma in Thai Patients. Asian Pac J Cancer Prev. 2020;21(6):1679-87. Search in Google Scholar

19 Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. Search in Google Scholar

20 McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22(3):276-82. Search in Google Scholar

21 The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews: Checklist for Analytical Cross Sectional Studies [Internet]. [cited 20 October 2021]. Available from: https://jbi.global/critical-appraisal-tools. Search in Google Scholar

22 Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews: Checklist for Cohort Studies [Internet]. [cited 20 October 2021]. Available from: https://jbi.global/sites/default/files/2020-08/Checklist_for_Cohort_Studies.pdf. Search in Google Scholar

23 Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews: Checklist for Case-Control Studies [Internet]. [cited 20 October 2021]. Available from: https://jbi.global/sites/default/files/2020-08/Checklist_for_Case_Control_Studies.pdf. Search in Google Scholar

24 Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews: Checklist for Randomized Controlled Trials [Internet]. [cited 20 October 2021]. Available from: https://jbi.global/sites/default/files/2020-08/Checklist_for_RCTs.pdf. Search in Google Scholar

25 OCEBM Levels of Evidence Working Group. “The Oxford Levels of Evidence 2”. [Internet]. Oxford Centre for Evidence-Based Medicine. [cited 1 November 2022]. Available from: https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence. Search in Google Scholar

26 Lin GSS, Hisham ARB, Cher CIY, Cheah KK, Ghani N, Noorani TY. Success rates of coronal and partial pulpotomies in mature permanent molars: a systematic review and single-arm meta-analysis. Quintessence Int. 2021;52(1):196-208. Search in Google Scholar

27 Landis JR, Koch GG. The Measurement of Observer Agreement for Categorical Data. Biometrics. 1977;33(1). Search in Google Scholar

28 Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14(2):467-75. Search in Google Scholar

29 Ndiaye C, Mena M, Alemany L, Arbyn M, Castellsagué X, Laporte L, et al. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. The Lancet Oncology. 2014;15(12):1319-31. Search in Google Scholar

30 Stein AP, Saha S, Kraninger JL, Swick AD, Yu M, Lambert PF, et al. Prevalence of Human Papillomavirus in Oropharyngeal Cancer: A Systematic Review. Cancer J. 2015;21(3):138-46. Search in Google Scholar

31 Termine N, Panzarella V, Falaschini S, Russo A, Matranga D, Lo Muzio L, et al. HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Ann Oncol. 2008;19(10):1681-90. Search in Google Scholar

32 Prabhu SR, Wilson DF. Human papillomavirus and oral disease - emerging evidence: a review. Aust Dent J. 2013;58(1):2-10; quiz 125. Search in Google Scholar

33 Kim KS, Park SA, Ko KN, Yi S, Cho YJ. Current status of human papillomavirus vaccines. Clin Exp Vaccine Res. 2014;3(2):168-75. Search in Google Scholar

34 D’Souza G, Cullen K, Bowie J, Thorpe R, Fakhry C. Differences in oral sexual behaviors by gender, age, and race explain observed differences in prevalence of oral human papillomavirus infection. PLoS One. 2014;9(1):e86023. Search in Google Scholar

35 Tachezy R, Klozar J, Salakova M, Smith E, Turek L, Betka J, et al. HPV and other risk factors of oral cavity/oropharyngeal cancer in the Czech Republic. Oral Dis. 2005;11(3):181-5. Search in Google Scholar

36 Crotty TJ, Keane E, Cousins G, Brennan S, Kinsella J, Moran T. Sexual Behaviour and Human Papillomavirus-Positive Oral Cavity and Oropharyngeal Cancer: An Irish Perspective. Cureus. 2020;12(11):e11410. Search in Google Scholar

37 Murthy V, Calcuttawala A, Chadha K, d’Cruz A, Krishnamurthy A, Mallick I, et al. Human papillomavirus in head and neck cancer in India: Current status and consensus recommendations. South Asian J Cancer. 2017;6(3):93-8. Search in Google Scholar

38 Shaikh MH, McMillan NA, Johnson NW. HPV-associated head and neck cancers in the Asia Pacific: A critical literature review & meta-analysis. Cancer Epidemiol. 2015;39(6):923-38. Search in Google Scholar

39 Ragin C, Liu JC, Jones G, Shoyele O, Sowunmi B, Kennett R, et al. Prevalence of HPV infection in racial–ethnic subgroups of head and neck cancer patients. Carcinogenesis. 2017;38(2):218-29. Search in Google Scholar

40 Gotz C, Bischof C, Wolff KD, Kolk A. Detection of HPV infection in head and neck cancers: Promise and pitfalls in the last ten years: A meta-analysis. Mol Clin Oncol. 2019;10(1):17-28. Search in Google Scholar

41 Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med. 2001;344(15):1125-31. Search in Google Scholar

42 Mackay J, Ritthiphakdee B, Reddy KS. Tobacco control in Asia. The Lancet. 2013;381(9877):1581-7. Search in Google Scholar

43 Yan H, Chen W, Wu H, Bi Y, Zhang M, Li S, et al. Multiple sex partner behavior in female undergraduate students in China: a multi-campus survey. BMC Public Health. 2009;9:305. Search in Google Scholar

44 Albers AE, Qian X, Kaufmann AM, Coordes A. Meta analysis: HPV and p16 pattern determines survival in patients with HNSCC and identifies potential new biologic subtype. Sci Rep. 2017;7(1):16715. Search in Google Scholar

45 Kim SM. Human papilloma virus in oral cancer. J Korean Assoc Oral Maxillofac Surg. 2016;42(6):327-36. Search in Google Scholar

46 Prigge ES, Arbyn M, von Knebel Doeberitz M, Reuschenbach M. Diagnostic accuracy of p16(INK4a) immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis. Int J Cancer. 2017;140(5):1186-98. Search in Google Scholar

47 Qureishi A, Winter S. Letter to editor: Current and future techniques for human papilloma virus (HPV) testing in oropharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2017;274(12):4259. Search in Google Scholar

48 Kumar B, Cordell KG, Lee JS, Worden FP, Prince ME, Tran HH, et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol. 2008;26(19):3128-37. Search in Google Scholar

49 Dayyani F, Etzel CJ, Liu M, Ho CH, Lippman SM, Tsao AS. Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol. 2010;2:15. Search in Google Scholar

50 El-Naggar AK, Westra WH. p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretative relevance and consistency. Head Neck. 2012;34(4):459-61. Search in Google Scholar

51 Reuschenbach M, Tinhofer I, Wittekindt C, Wagner S, Klussmann JP. A systematic review of the HPV-attributable fraction of oropharyngeal squamous cell carcinomas in Germany. Cancer Med. 2019;8(4):1908-18. Search in Google Scholar

52 Attner P. HPV prevalence in the different subsites of the oropharynx. Journal of Clinical Oncology. 2013;31(15_suppl):6037-. Search in Google Scholar